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Abstract 
The conformation of [D-MeSe?-D-Ser-(O-Gly)*]CS, a water soluble cyclosporin derivative, has been determined in (D,)DMSO and in water using 
NMR. In these polar solvents the conformation is identical and very similar to the structure found in the cyclophilin-cyclosporin complex. However, 
it differs significantly from its conformation in deuterated chloroform. This demonstrates unambiguously that the large structure change is induced 
primarily by the polar solvent rather than by complex formation with cyclophilin. 
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1. Introduction 
Cyclosporin A (CS) [l] (Fig. 1) is a powerful immuno- 
suppressor of T cells [2]. It binds to an endogenous intra- 
cellular receptor called cyclophilin A (CYP), and the 
resulting complex targets the protein phosphatase cal- 
cineurin A [3,4]. The structures of CS in single crystals 
and in apolar solvents have been determined and found 
to be similar [5-71. They were described as a rather rigid 
conformation with three transannular hydrogen-bonds, 
one cis amide linkage and all hydrophobic carbon chains 
exposed to solvent. The structure of CS bound to its 
receptor CYP has been revealed by NMR techniques 
[8-lo] and by X-ray analysis of a decameric [l l] and of 
a monomeric [12] CYP-CS complex. The conformation 
of CS on CYP is significantly different from the structure 
in single crystals or apolar solvents. It has all peptide 
bonds in the trans form, no intramolecular NH bridged 
carbonyl and exposes nearly all polar groups to its envi- 
ronment. Another major change is that the MeBmt-1 
residue is folded back onto the lower face of the molecule 
rather than onto the upper face when keeping the orien- 
tation of Fig. 1. The OH-group of MeBmt-1 points to the 
carbonyl of MeLeu-4 and holds the peptide turn of resi- 
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dues 1 to 4 together. This dramatic global rearrangement 
of the peptide backbone conformation of CS could not 
be predicted by molecular dynamics calculations [13,14]. 
It was assumed to be induced by the protein [ 15,161, but 
no corroborating evidence was available, and the confor- 
mation of uncomplexed CS in water was unknown. 
Kinetic and spectroscopic studies [17] with the aid of 
all-trans amide or 9,10-cis amide conformations [ 18,191 
of CS showed evidence of a time and solvent dependent 
inhibition of the peptidyl-prolyl cisltruns isomerase ac- 
tivity of CYP by CS and allowed the hypothesis that 
CYP could bind a conformation of CS already present 
in water [20], rather than inducing a new conformation. 
Here we address this problem by describing the NMR 
structdre of [D-MeSer3-D-Ser(O-Gly)‘]CS hydrochloride, 
a water soluble CS derivative, in (D,)DMSO and in 
water. 
2. Materials and methods 
The cyclosporin derivatives (D-MeSe?)CS and [D-Me&r”-D-.%r(@ 
Gly)‘]CS were synthesized starting from CS and (D-Ser’)CS [21], respec- 
tively, using known chemical techniques [l]. (D-Lys*)CS was obtained 
from total synthesis [22]. NMR experiments were acquired at 20°C on 
Bruker AMX400 and AM500 spectrometers. Sample conditions are 
given in the figure legends. Resonance assignments were obtained from 
2QF-COSY [23], TOCSY [24,25], and NOESY [26] experiments. The 
data used for structure determination of [D-Me&r’-D-Ser(O-Gly)*]CS 
in (D,)DMSO (4 mM) were obtained from a NOESY spectrum with 
a mixing time z, of 50 ms recorded at 500 MHz. The assigned peaks 
were integrated using the program EASY [27] and calibrated with the 
program CALIBA [28] applying a l/r6 relationship between peak vol- 
umes and upper distance limits. Supplementary angle constraints were 
obtained from the program HABAS [29] using Jcoupling constants and 
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the upper distance constraints as input data. Cyclization of the peptide 
between residues 1 and 11 was imposed by 9 exact distance constraints. 
1000 structures were calculated with the program DIANA [28,30] using 
the standard minimization protocol and one iteration cycle bf the 
REDAC procedure 1311. Stereosnecific assignments of 8-orotons were . - , 1 
obtained by analyses of preliminary DIANA structures with the pro- 
gram GLOMSA [28]. To define the set of final structures, the maximum 
of the pairwise backbone RMSDs was plotted vs. the target function 
cutoff value and the selection criteria described by Widmer et al. [30] 
were applied. 
3. Results and discussion 
NMR results show that a substitution of D-MeSer for 
Sar in position 3 of CS, as in (D-MeSer3)CS [l] (Fig. l), 
stabilizes a single conformation in (D,)DMSO and in 
water compared to multiple conformations of CS in 
these polar solvents (Fig. 2). On the other side, an amino 
group in position 8 of CS, as in (D-Lys’)CS, makes such 
a derivative water soluble and retains its good affinity for 
CYP and CS-antibodies [21]. [D-MeSer3-D-Ser-(O- 
Gly)*]CS (Fig. 1) contains both modifications, a stabiliz- 
ing D-MeSer-residue in position 3 and a solubilizing 
D-Ser-O-glycine ster residue in position 8. Its conforma- 
tion was investigated by NMR spectroscopy in CDCl,, 
(D,)DMSO and H20. In CDCl, the well known confor- 
mation [5-71 of CS with a 9,10-cis amide geometry was 
found (not shown). However, in the polar solvents used, 
a different, single conformation predominated (> 95%; 
Fig. 3). This is in contrast to present knowledge of CS 
and other CS derivatives which adopt many conforma- 
tions in polar solvents unless when complexed with a 
metal cation [18,32] or a protein [8-lo]. The conforma- 
tion of [D-MeSer3-D-Ser-(O-Gly)*]CS in (DJDMSO and 
in water is the same. This is supported by the finding of 
only one set of resonances in (D,)DMSO-water mixtures 
(Fig. 3) and, moreover, by the coincidence of the short 
and long range NOES observed in NOESY spectra meas- 
Fig. 1. Chemical structures of Cyclosporin A derivatives (conformation 
in apolar solvent shown) 
Cyclosporin A (CS) R, = H, R, = H 
(o-MeSe?)CS R, = CH,OH, R, = H [l] 111 
(D-Lys’)CS.HCl R, = H, R, = (CH,),NH,.HCl WI 
[D-MeSe?-D-Ser(@Gly)*] R, = CH,OH, 
CS.HCl RZ = 0-CO-CH,NH* HCl 111 
Fig. 2. ‘H-NMR spectra (400 MHz) of (a) Cyclosporin A (CS) and 
(b) (o-MeSer’)CS in (DJDMSO, concentration 4 mM, at 20°C. (c) 
N-Methyl region of an NMR spectrum of a saturated solution of 
(o-MeSer3)CS in HzO, pH 6.9. The stabilizing effect of the D-MeSer 
residue in position 3 is manifested by observing only one set of reso- 
nances (b and c) as compared to multiple sets for CS (a). The chemical 
structure of (D-MeSer’)CS is represented in the CYP-bound conforma- 
tion. 
ured in both solvents (not shown). Due to this conforma- 
tional identity in DMSO and water it is sufficient to 
determine the structure in one solvent only. The conclu- 
sions will then be valid for both systems. The complete 
3D structure was determined using data collected in 
(DJDMSO. From a NOESY with 50ms mixing time 83 
meaningful upper distance constraints were obtained. 
namely from 38 intraresidual, 30 sequential, and 15 me- 
dium and long range NOES. They were used in distance 
geometry calculations with the program DIANA. The 
selected set of final structures consists of 47 conforma- 
tions (Fig. 4). They have very low residual constraints 
violations and are well defined (Table 1). The average of 
the backbone RMSD among all pairs of 47 NMR struc- 
tures is 0.25 A. They are nearly identical to the structure 
of CS complexed to CYP [l 1,121 (Fig. 4). The pairwise 
backbone RMSD between the X-ray structure and the 
individual NMR structures is on average 0.47 A; the 
maximum is 0.77 A, which is similar to the maximum 
RMSD of 0.72 A among the NMR structures (Table 1). 
The hydrogen bond between the B-hydroxyl of MeBmt-1 
and the carbonyl of MeLeu-4 observed in the complex 
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Fig. 3. ‘H-NMR spectrum of [D-MeSer3-n-Ser(@Cly)s]CS.HCl in water at 400 MHz and 2O”C, concentration 4 mM, pH 5.6 (addition of NaOH 
to give pH 7.0 gave an identical spectrum). In the insert (a-c) the N-methyl regions of NMR spectra measured in solvent mixtures [34] are shown; 
(a) (D,)DMSO, (b) (DdDMSO: H20 (4:1), (c) (D,)DMSO: Hz0 (1:4). The chemical structure of [D-MeSer3-D-Ser(O-G1y)‘]cs is represented in the 
CYP-bound conformation. 
with CYP [l 1,121 is also found in 26 of the 47 uncom- 
plexed solution structures. The CYP-bound CS confor- 
mation fits into the envelope of the NMR structures at 
all residues except MeVal-11 (Fig. 4). The displacement 
between the C” position in the average NMR structure 
and the corresponding C” atom in the X-ray structure is 
0.83 A for MeVal-11 and < 0.6 A for all other residues. 
This structure determination of [D-MeSer3-D-&r-(@ 
Gly)‘]CS provides, for the first time, evidence that a free 
CS analogue adopts the CYP-bound CS conformation 
in (D,)DMSO and in water. The concept of a ‘receptor- 
induced conformation’ [l&16] applies only to MeVal-11 
which is ‘sucked’ into the binding pocket of CYP. 
The equilibrium affinity constants for (D-MeSer3)CS 
and [D-MeSer3-p-Ser(O-Gly)8]CS to CYP initially dis- 
solved in DMSO have been found to be about 10 times 
higher than that of CS (Van Regemnortel et al., to be 
published). The kinetics of CYP binding to [D-MeSer3-D- 
Ser(O-Gly)8]CS was monitored by measuring 1D NMR 
and found to be 90% complete within three minutes (not 
shown). This is in contrast to CS, which requires 3045 
min for complex formation with CYP [17,33] and sup- 
ports the hypothesis that CS has to undergo structural 
changes before complex formation with CYP in a rate 
limiting step. 
Our results confirm that the cyclophilin bound confor- 
mation is a good model for discussing structure activity 
relationships of cyclosporins and show, for the first time, 
that through a minor structure change in position 3, it 
is possible to obtain the cyclophilin-bound cyclosporin 
conformation free in water. 
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Table 1 
Analysis of the 47 NMR structures of [D-MeSeP-D-Ser(@Gly)*]CS in
(DdDMSO and comparison with the X-ray structure of CS in the CYP 
complex 1121 
Parameter Average value 
(min, max) 
DIANA target function (A2) 
Residual NOE violations (A) 
Sum 
Maximum 
Residual Van der Waals violations (A) 
Sum 
Maximum 
0.29 (0.19, 0.37) 
0.55 (0.3, 0.9) 
0.14 (0.07, 0.29) 
1.3 (1.0, 1.6) 
Pairwise RMSDs (A): NMR structures 
0.16 (0.14, 0.22) 
Backbone atoms (N, c”, C’) 0.25 (0.04, 0.72) 
Heavy atoms* 0.57 (0.21, 1.18) 
Pairwise RMSDs (A): X-ray vs. NMR 
structures 
Backbone atoms (N, c”, C’) 0.47 (0.35, 0.77) 
Heavy atoms*.+ 0.75 (0.59, 1.10) 
*Only atoms up to the y-positions of the side chains are included, so 
that variants of the 2 angles and beyond are not considered. 
‘In residues 3 and 8 only atoms which have a corresponding atom in 
CS are considered. 
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Fig. 4. Stereoviev i’C If the NMR structures of uncomplexed [n-MeSer3-o-Ser(O-Gly)8]CS in (D,)DMSO solution (cyan) superimposed with the X-ray 
strut :ture of cycle ,PJ tilin-bound CS [12] (yellow). (a) Representation with backbone atoms C’,C”, and N: 47 NMR structures are she lwn. (b) Heavy 
aton i representati orI: the NMR structure with lowest backbone RMSD (0.35 A) to the X-ray structure is shown: the target function c ralue is 0 .30 A?. 
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